Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Blood

• Publication date

  2007-11-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2007-06-093823PMID 17993614PMCID PMC2214759
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma.

  2006cited by this paper
• Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma

  2005cited by this paper
• The Influence of Age on T Cell Generation and TCR Diversity1

  2005cited by this paper
• Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia.

  2005cited by this paper
• FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells

  2004cited by this paper
• Homeostatic control of T-cell generation in neonates.

  2003cited by this paper
• The active caspase-8 heterotetramer is formed at the CD95 DISC

  2003cited by this paper
• Differential effects of interleukin-2 blockade on apoptosis in naïve and activated human lymphocytes12

  2003cited by this paper
• Survival signals in leukemic large granular lymphocytes.

  2003cited by this paper
• Constitutive Caspase Activation and Impaired Death-Inducing Signaling Complex Formation in CD95-Resistant, Long-Term Activated, Antigen-Specific T Cells

  2003cited by this paper
• Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia.

  2003cited by this paper
• Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells.

  2002cited by this paper
• Molecular Ordering of the Initial Signaling Events of CD95

  2002cited by this paper
• Skewed maturation of memory HIV-specific CD8 T lymphocytes

  2001cited by this paper
• 11-color, 13-parameter flow cytometry: Identification of human naive T cells by phenotype, function, and T-cell receptor diversity

  2001cited by this paper
• Cellular FLICE-inhibitory Protein Splice Variants Inhibit Different Steps of Caspase-8 Activation at the CD95 Death-inducing Signaling Complex*

  2001cited by this paper
• Molecular Mechanisms of Death‐Receptor‐Mediated Apoptosis

  2001cited by this paper
• Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.

  2001cited by this paper
• Molecular and flow cytometric analysis of the Vbeta repertoire for clonality assessment in mature TCRalphabeta T-cell proliferations.

  2001cited by this paper
• Coincident myelodysplastic syndrome and T‐cell large granular lymphocytic disease: clinical and pathophysiological features

  2001cited by this paper
• Large granular lymphocyte leukaemia is characterized by a clonal T‐cell receptor rearrangement in both memory and effector CD8+ lymphocyte populations

  2001cited by this paper
• Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide.

  2000cited by this paper
• The Role of c-FLIP in Modulation of CD95-induced Apoptosis*

  1999cited by this paper
• Isolation and analysis of components of CD95 (APO-1/Fas) death-inducing signaling complex.

  1999cited by this paper
• Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

  1999cited by this paper
• Bcl-xL Acts Downstream of Caspase-8 Activation by the CD95 Death-inducing Signaling Complex*

  1998cited by this paper
• Expression of FAP-1 (Fas-Associated Phosphatase) and Resistance to Fas-Mediated Apoptosis in T Cell Lines Derived from Human T Cell Leukemia Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis Patients

  1998cited by this paper
• Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia

  1998cited by this paper
• Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.

  1998cited by this paper
• Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3+ large granular lymphocyte leukemia

  1998cited by this paper
• FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC)

  1997cited by this paper
• Inhibition of death receptor signals by cellular FLIP

  1997cited by this paper
• Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions.

  1997cited by this paper
• I-FLICE, a Novel Inhibitor of Tumor Necrosis Factor Receptor-1- and CD-95-induced Apoptosis*

  1997cited by this paper
• Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

  1997cited by this paper
• CASH, a Novel Caspase Homologue with Death Effector Domains*

  1997cited by this paper
• FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis*

  1997cited by this paper
• Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)

  1995cited by this paper
• Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation

  1995cited by this paper
• Altered representation of naive and memory CD8 T cell subsets in HIV-infected children.

  1995cited by this paper
• Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.

  1995cited by this paper
• The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice.

  1994cited by this paper
• Clonal diseases of large granular lymphocytes.

  1993cited by this paper
• Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

  1992cited by this paper
• Activation of leukemic large granular lymphocytes by interleukin-2 via the p75 interleukin-2 receptor.

  1990cited by this paper
• Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia.

  1987cited by this paper
• Letter: Clonidine withdrawal and blockade.

  1976cited by this paper

• T Cell Repertoire Analysis as a Molecular Signature of the Spectrum of T-LGL Lymphoproliferative Disorders: Tracing the Literature

  2025cites this paper
• Models for T-large granular lymphocytic leukemia: how to mimic the cellular interplays in malignant autoimmunity

  2025cites this paper
• Immune Checkpoints and Their Inhibition in T-Cell Lymphomas.

  2024cites this paper
• A modern view of LGL leukemia.

  2024cites this paper
• Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment

  2024cites this paper
• HSP and CD279 gene expression as candidate biomarkers in symptomatic LGLL patients

  2024cites this paper
• T-large granular lymphocyte frequencies and correlates in disease states detected by multiparameter flow cytometry in pediatric and young adult population

  2023influential citation
• Large granular lymphocyte leukemia: An indolent clonal proliferative disease associated with an array of various immunologic disorders.

  2023cites this paper
• Not all LGL leukemias are created equal.

  2023cites this paper
• Effective Treatment with the Selective Cytokine Inhibitor BNZ-1 Reveals the Cytokine Dependency of T-LGL Leukemia.

  2023cites this paper
• Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis

  2022cites this paper
• Toward a Better Classification System for NK-LGL Disorders

  2022cites this paper
• Cytokines in the Pathogenesis of Large Granular Lymphocytic Leukemia

  2022influential citation
• T-sejtes nagy granuláris lymphocytás leukémia ezer arca és sikeres kezelése

  2022cites this paper
• Thymoma With Triple Threat: Pure Red Cell Aplasia, Autoimmune Hemolytic Anemia, and T-Cell Large Granular Lymphocytic Leukemia

  2022cites this paper
• Large granular lymphocytic leukemia: a brief review.

  2022cites this paper
• Large granular lymphocyte leukaemia study at the University Hospital of Donostia

  2021cites this paper
• miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia

  2021cites this paper
• Large Granular Lymphocyte Expansion in Myeloid Diseases and Bone Marrow Failure Syndromes: Whoever Seeks Finds

  2021cites this paper
• Immunologic effects on the haematopoietic stem cell in marrow failure.

  2021cites this paper
• Large Granular Lymphocyte Leukemia

  2021cites this paper
• Large Granular Lymphocyte Leukemia

  2021cites this paper
• Sensitization to cell death induced by soluble Fas ligand and agonistic antibodies with exogenous agents: A review

  2020cites this paper
• Clinical outcomes in T‐cell large granular lymphocytic leukaemia: prognostic factors and treatment response

  2020cites this paper
• Large Granular Lymphocyte Leukemia

  2019cites this paper
• T cell large granular lymphocyte leukemia and chronic NK lymphocytosis.

  2019cites this paper
• Dysfunction of immune system in the development of large granular lymphocyte leukemia

  2018cites this paper
• Donor derived T-cell large granular lymphocyte leukemia after cord blood transplant for pediatric T-cell lymphoblastic leukemia

  2018cites this paper
• Paraneoplastische, Pyoderma gangraenosum‐artige Ulzeration bei T‐Zell‐Leukämie mit großen granulären Zellen (T‐Zell‐LGL‐Leukämie)

  2018cites this paper
• TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia.

  2018cites this paper
• Mixed-phenotype large granular lymphocytic leukemia: a rare subtype in the large granular lymphocytic leukemia spectrum.

  2018cites this paper
• AN INSIGHT INTO THE MECHANISMS OF ABACAVIR INDUCED HYPERSENSITIVITY REACTIONS WITH A VIEW TO DESIGNING SAFER THERAPEUTICS.

  2018cites this paper
• Paraneoplastic pyoderma gangrenosum‐like ulceration in T‐cell large granular lymphocytic leukemia

  2017cites this paper
• Large granular lymphocyte leukemia and pulmonary hypertension : an unusual association

  2017cites this paper
• LGL leukemia: from pathogenesis to treatment.

  2017influential citation
• Chronic neutropenia in LGL leukemia and rheumatoid arthritis.

  2017cites this paper
• STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia.

  2017cites this paper
• Large granular lymphocytic leukemia. Current diagnostic and therapeutic approaches and novel treatment options

  2017cites this paper
• [Combined variable immunodeficiency with unusal features. A case report].

  2015cites this paper
• PERIODONTITIS AS A MANIFESTATION OF LARGE GRANULAR LYMPHOCYTE ( LGL ) LEUKEMIA : A CASE REPORT

  2015cites this paper
• The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia

  2015cites this paper
• Présentation atypique d’un déficit immun commun variable. À propos d’un cas

  2015cites this paper
• Large granular lymphocyte leukemia: clinical background, molecular pathogenesis and treatment

  2015cites this paper
• Good syndrome presenting with CD8+ T-Cell large granular lymphocyte leukemia

  2015cites this paper
• The pathogenesis and treatment of large granular lymphocyte leukemia.

  2014cites this paper
• Familial CD3+ T large granular lymphocyte leukemia: evidence that genetic predisposition and antigen selection promote clonal cytotoxic T-cell responses

  2014cites this paper
• FLIP: Molecular switch between apoptosis and necroptosis

  2014cites this paper
• Hypothesis: Concordance of Gaucher disease and large granular lymphocytic leukemia has biological plausibility.

  2014cites this paper
• [Large granular lymphocytic leukemia. A rare disease with personalized treatment options].

  2014cites this paper
• Treating rare lymphoproliferative malignancies: a focus on indolent large granular lymphocytic leukemia

  2014cites this paper
• Lack of common TCRA and TCRB clonotypes in CD8+/TCRαβ+ T-cell large granular lymphocyte leukemia: a review on the role of antigenic selection in the immunopathogenesis of CD8+ T-LGL

  2014cites this paper
• Uncovering the pathogenesis of large granular lymphocytic leukemia—novel STAT3 and STAT5b mutations

  2014cites this paper
• Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)

  2014cites this paper
• Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder Really Two Distinct Diseases?

  2014cites this paper
• Emergence of a STAT3 mutated NK clone in LGL leukemia

  2014cites this paper
• The T-Cell Leukaemias

  2013cites this paper
• Fibrosis and Subsequent Cytopenias Are Associated with Basic Fibroblast Growth Factor–Deficient Pluripotent Mesenchymal Stromal Cells in Large Granular Lymphocyte Leukemia

  2013cites this paper
• Identification of Somatic Mutations in LGL Leukemia through Whole Genome Sequencing and Correlation of STAT3 Y640F Mutation with Treatment Response to Methotrexate.

  2013cites this paper
• Is Urinary Soluble Fas an Independent Predictor of Non-Muscle-Invasive Bladder Cancer? A Prospective Chart Study

  2013cites this paper
• This information is current as Leukemia LymphocyteStromal Cells in Large Granular Deficient Pluripotent Mesenchymal − Factor Associated with Basic Fibroblast Growth Fibrosis and Subsequent Cytopenias Are and

  2013cites this paper
• Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment.

  2012cites this paper
• Novel and emerging drugs for rarer chronic lymphoid leukaemias.

  2012cites this paper
• Soluble Fas and Fas ligand and prognosis in children with acute lymphoblastic leukemia

  2012cites this paper
• Somatic STAT3 mutations in large granular lymphocytic leukemia.

  2012cites this paper
• Tipifarnib-mediated suppression of T-bet-dependent signaling pathways

  2012cites this paper
• T-cell large granular lymphocytosis associated with malignant thymoma.

  2012cites this paper
• Bfl-1 in Leukemic T CellsB and Mitochondrial k Downregulation of NF-Fas-Induced Apoptosis through Suppressors of Cytokine Signaling Promote

  2012cites this paper
• Suppressors of Cytokine Signaling Promote Fas-Induced Apoptosis through Downregulation of NF-κB and Mitochondrial Bfl-1 in Leukemic T Cells

  2012cites this paper
• Bone Marrow Involvement in Primary Mature B and T Cell Leukemias

  2012cites this paper
• Large Granular Lymphocyte Leukemia – From Molecular Pathogenesis to Targeted Therapy

  2012cites this paper
• Autoimmune manifestations in large granular lymphocyte leukemia.

  2012cites this paper
• Advances in diagnosis and treatment of large granular lymphocyte syndrome

  2011cites this paper
• How I treat LGL leukemia.

  2011cites this paper
• Effects of Toll-like receptor signals in T-cell neoplasms.

  2011cites this paper
• Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemia

  2011cites this paper
• Large granular lymphocytic leukaemia pathogenesis and management

  2011cites this paper
• Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia.

  2011cites this paper
• Molecular Biology of Chronic Lymphoproliferative Disorders

  2011cites this paper
• Dynamical and Structural Analysis of a T Cell Survival Network Identifies Novel Candidate Therapeutic Targets for Large Granular Lymphocyte Leukemia

  2011cites this paper
• The Spectrum of T-cell and Natural Killer – Large Granular Lymphocytic Proliferations

  2010cites this paper
• Long-term safety and efficacy of cyclosporin A therapy for T-cell large granular lymphocyte leukemia

  2010cites this paper
• T‐Cell Lymphoproliferative Disorders

  2010cites this paper
• A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.

  2010cites this paper
• MICA polymorphism identified by whole genome array associated with NKG2D-mediated cytotoxicity in T-cell large granular lymphocyte leukemia

  2010cites this paper
• Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches

  2009cites this paper
• Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon.

  2009cites this paper
• Role of sphingolipid signaling in pathogenesis of large granular lymphocyte leukemia

  2009cites this paper
• Never say die: survival signaling in large granular lymphocyte leukemia.

  2009cites this paper
• The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders

  2009cites this paper
• Network model of survival signaling in large granular lymphocyte leukemia

  2008cites this paper
• Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway.

  2008cites this paper
• Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes.

  2008cites this paper
• A "pathogenetic" role for CMV in CD4+ LGL proliferations.

  2008cites this paper
• T/B and not T/B: High frequency of B-cell dyscrasias in T-LGL leukemia

  2008cites this paper